RHO to the DOCK for GDP disembarking: Structural insights into the DOCK GTPase nucleotide exchange factors

Autor: J.L. Gray, Christina Bitsina, Frank von Delft, Paul Brennan, Andrew P. Thompson
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Protein Conformation
aPKC
atypical protein kinase

dedicator of cytokinesis (DOCK)
GTPase
Biology
guanosine triphosphate (GTP)
Ras homologous (RHO) small GTPases
AD
Alzheimer’s disease

Biochemistry
PAK
p21-activated kinase

drug discovery
GTP Phosphohydrolases
GEF
guanine nucleotide exchange factor

03 medical and health sciences
GTP
guanosine triphosphate

APP
amyloid precursor protein

DOCK
Catalytic Domain
MRCK
myotonic dystrophy kinase-related CDC42-binding kinase

guanine nucleotide exchange factor
cell signaling
structural biology
Cytoskeleton
Molecular Biology
GDP
guanosine diphosphate

030102 biochemistry & molecular biology
Drug discovery
DHR2 domain
JBC Reviews
GDI
GDP dissociation inhibitor

Cell Biology
CDOCK
dedicator of cytokinesis

Cell biology
030104 developmental biology
Structural biology
Guanine nucleotide exchange factor
Cytokinesis
Rho Guanine Nucleotide Exchange Factors
Zdroj: The Journal of Biological Chemistry
ISSN: 1083-351X
0021-9258
Popis: The human dedicator of cytokinesis (DOCK) family consists of 11 structurally conserved proteins that serve as atypical RHO guanine nucleotide exchange factors (RHO GEFs). These regulatory proteins act as mediators in numerous cellular cascades that promote cytoskeletal remodeling, playing roles in various crucial processes such as differentiation, migration, polarization, and axon growth in neurons. At the molecular level, DOCK DHR2 domains facilitate nucleotide dissociation from small GTPases, a process that is otherwise too slow for rapid spatiotemporal control of cellular signaling. Here, we provide an overview of the biological and structural characteristics for the various DOCK proteins and describe how they differ from other RHO GEFs and between DOCK subfamilies. The expression of the family varies depending on cell or tissue type, and they are consequently implicated in a broad range of disease phenotypes, particularly in the brain. A growing body of available structural information reveals the mechanism by which the catalytic DHR2 domain elicits nucleotide dissociation and also indicates strategies for the discovery and design of high-affinity small-molecule inhibitors. Such compounds could serve as chemical probes to interrogate the cellular function and provide starting points for drug discovery of this important class of enzymes.
Databáze: OpenAIRE